BioCentury
ARTICLE | Company News

Harbour Antibodies, Shang Pharma deal

September 17, 2012 7:00 AM UTC

ShangPharma will use Harbour's human immunoglobulin-gene transgenic mice for human antibody development services. The mice produce IgG antibodies with human variable regions. The companies could not b...